International Journal of Health Policy and Management

International Journal of Health Policy and Management

Barriers and Opportunities for WHO ‘Best Buys’ Non-Communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review

Document Type : Review Article

Authors
Giulia Loffreda 1
Stella Arakelyan 2, 1
Ibrahim Bou-Orm 1
Hampus Holmer 3
Luke N. Allen 4
Sophie Witter 1
Alastair Ager 1
Karin Diaconu 1
1 NIHR Research Unit of Health in Fragility, Institute for Global Health and Development, Queen Margaret University Edinburgh, Musselburgh, UK
2 Advanced Care Research Centre, Usher Institute, University of Edinburgh, Edinburgh, UK
3 Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
4 Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK
10.34172/ijhpm.2023.7989
Abstract
Background
Improving the adoption and implementation of policies to curb non-communicable diseases (NCDs) is a major challenge for better global health. The adoption and implementation of such policies remain deficient in various contexts, with limited insights into the facilitating and inhibiting factors. These policies have traditionally been treated as technical solutions, neglecting the critical influence of political economy dynamics. Moreover, the complex nature of these interventions is often not adequately incorporated into evidence for policy-makers. This study aims to systematically review and evaluate the factors affecting NCD policy adoption and implementation.

Methods
We conducted a complex systematic review of articles discussing the adoption and implementation of World Health Organization’s (WHO’s) “best buys” NCD policies. We identified political economy factors and constructed a causal loop diagram (CLD) program theory to elucidate the interplay between factors influencing NCD policy adoption and implementation. A total of 157 papers met the inclusion criteria.

Results
Our CLD highlights a central feedback loop encompassing three vital variables: (1) the ability to define, (re)shape, and pass appropriate policy into law; (2) the ability to implement the policy (linked to the enforceability of the policy and to addressing NCD local burden); and (3) ability to monitor progress, evaluate and correct the course. Insufficient context-specific data impedes the formulation and enactment of suitable policies, particularly in areas facing multiple disease burdens. Multisectoral collaboration plays a pivotal role in both policy adoption and implementation. Effective monitoring and accountability systems significantly impact policy implementation. The commercial determinants of health (CDoH) serve as a major barrier to defining, adopting, and implementing tobacco, alcohol, and diet-related policies.

Conclusion
To advance global efforts, we recommend focusing on the development of robust accountability, monitoring, and evaluation systems, ensuring transparency in private sector engagement, supporting context-specific data collection, and effectively managing the CDoH. A system thinking approach can enhance the implementation of complex public health interventions.

Highlights

Commentaries Published on this Paper

 

  • Acting on the Evidence: The Challenges Facing Policy and Practice; Comment on “Barriers and Opportunities for WHO “Best Buys” Non-Communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review

        Abstract | PDF

 

  • Future Best Buys Can and Should Do More; Comment on “Barriers and Opportunities for WHO ‘Best Buys’ Non-Communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review”

        Abstract | PDF

 

  • No Time Like the Present: Centring Politics in the Global NCD Policy Agenda; Comment on “Barriers and Opportunities for WHO ‘Best Buys’ Non-Communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review”

        Abstract | PDF

 

  • Finding the Right Balance: Challenges in Optimising the Promise of Complexity Research for NCD Best-Buys Implementation and Adoption; Comment on “Barriers and Opportunities for WHO ‘Best Buys’ Non-communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review”

        Abstract | PDF

 

  • Towards Implementation of Equitable and Effective Non-Communicable Disease Policies; Comment on “Barriers and Opportunities for WHO ‘Best Buys’ Non-Communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review”

        Abstract | PDF

 

Authors' Response to the Commentaries

 

  • Advancing Technical, Research, and Political Engagement in the Prevention of Non-communicable Disease: A Response to Recent Commentaries

        Abstract | PDF

 

Keywords
Best Buys
NCD Policies and Interventions
Complexity Theory
Implementation Research
  1. World Health Organization (WHO). Tackling NCDs. WHO; 2017.
  2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-2128. doi:1016/s0140-6736(12)61728-0
  3. World Health Organization (WHO). Global Status Report on Noncommunicable Diseases 2010. WHO; 2010.
  4. World Health Organization (WHO). From Burden to 'Best Buys': Reducing the Economic Impact of NCDs in Low- and Middle-Income Countries. WHO; 2011.
  5. World Health Organization (WHO). Global Action Plan for the Prevention and Control of NCDs 2013-2020. WHO; 2013.
  6. World Health Organization (WHO). Political Declaration of the Third High-Level Meeting of the General Assembly on the Prevention and Control of Non-Communicable Diseases, and Mental Health. WHO; 2023. https://apps.who.int/gb/ebwha/pdf_files/EB152/B152_6-en.pdf.
  7. World Health Organization (WHO). 'Best Buys' and Other Recommended Interventions for the Prevention and Control of Noncommunicable Diseases. WHO; 2013.
  8. Allen LN, Nicholson BD, Yeung BYT, Goiana-da-Silva F. Implementation of non-communicable disease policies: a geopolitical analysis of 151 countries. Lancet Glob Health. 2020;8(1):e50-e58. doi:1016/s2214-109x(19)30446-2
  9. Allen LN, Pullar J, Wickramasinghe KK, et al. Evaluation of research on interventions aligned to WHO “best buys” for NCDs in low-income and lower-middle-income countries: a systematic review from 1990 to 2015. BMJ Glob Health. 2018;3(1):e000535. doi:1136/bmjgh-2017-000535
  10. Peters DH, Peters MA, Wickramasinghe K, Osewe PL, Davidson PM. Asking the right question: implementation research to accelerate national non-communicable disease responses. BMJ. 2019;365:l1868. doi:1136/bmj.l1868
  11. Peters DH, Adam T, Alonge O, Agyepong IA, Tran N. Implementation research: what it is and how to do it. BMJ. 2013;347:f6753. doi:1136/bmj.f6753
  12. Elliott LM, Dalglish SL, Topp SM. Health taxes on tobacco, alcohol, food and drinks in low- and middle-income countries: a scoping review of policy content, actors, process and context. Int J Health Policy Manag. 2022;11(4):414-428. doi:34172/ijhpm.2020.170
  13. Shiell A, Hawe P, Gold L. Complex interventions or complex systems? Implications for health economic evaluation. BMJ. 2008;336(7656):1281-1283. doi:1136/bmj.39569.510521.AD
  14. World Health Organization (WHO). A Guide to Implementation Research in the Prevention and Control of Noncommunicable Diseases. WHO; 2016.
  15. Buse K, Mays N, Walt G. Making Health Policy. Berkshire, England: Open University Press; 2012.
  16. Fritz V, Kaiser K, Levy B. Problem-Driven Governance and Political Economy Analysis: Good Practice Framework. Washington, DC: World Bank; 2009.
  17. Reich MR. Political economy of non-communicable diseases: from unconventional to essential. Health Syst Reform. 2019;5(3):250-256. doi:1080/23288604.2019.1609872
  18. Petticrew M, Knai C, Thomas J, et al. Implications of a complexity perspective for systematic reviews and guideline development in health decision making. BMJ Glob Health. 2019;4(Suppl 1):e000899. doi:1136/bmjgh-2018-000899
  19. Trochim WM, Cabrera DA, Milstein B, Gallagher RS, Leischow SJ. Practical challenges of systems thinking and modeling in public health. Am J Public Health. 2006;96(3):538-546. doi:2105/ajph.2005.066001
  20. Leischow SJ, Milstein B. Systems thinking and modeling for public health practice. Am J Public Health. 2006;96(3):403-405. doi:2105/ajph.2005.082842
  21. Lewin S, Hendry M, Chandler J, et al. Assessing the complexity of interventions within systematic reviews: development, content and use of a new tool (iCAT_SR). BMC Med Res Methodol. 2017;17(1):76. doi:1186/s12874-017-0349-x
  22. Lewin S, Booth A, Glenton C, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings: introduction to the series. Implement Sci. 2018;13(Suppl 1):2. doi:1186/s13012-017-0688-3
  23. Organization for Economic Co-operation and Development (OECD). States of Fragility 2020. Paris: OECD Publishing; 2020.
  24. Organization for Economic Co-operation and Development (OECD). States of Fragility 2022. Paris: OECD Publishing; 2022. doi:1787/ba7c22e7-en
  25. Carroll C, Booth A. Quality assessment of qualitative evidence for systematic review and synthesis: is it meaningful, and if so, how should it be performed? Res Synth Methods. 2015;6(2):149-154. doi:1002/jrsm.1128
  26. Popay J, Roberts H, Sowden A, et al. Guidance on the Conduct of Narrative Synthesis in Systematic Reviews. A Product from the ESRC Methods Programme. Version 1. https://www.lancaster.ac.uk/media/lancaster-university/content-assets/documents/fhm/dhr/chir/NSsynthesisguidanceVersion1-April2006.pdf. Published April 2006.
  27. Diaconu K, Falconer J, Vidal N, et al. Understanding fragility: implications for global health research and practice. Health Policy Plan. 2020;35(2):235-243. doi:1093/heapol/czz142
  28. Shearer JC, Abelson J, Kouyaté B, Lavis JN, Walt G. Why do policies change? Institutions, interests, ideas and networks in three cases of policy reform. Health Policy Plan. 2016;31(9):1200-1211. doi:1093/heapol/czw052
  29. Reich MR. Political economy analysis for health. Bull World Health Organ. 2019;97(8):514. doi:2471/blt.19.238311
  30. Isaranuwatchai W, Teerawattananon Y, Archer RA, et al. Prevention of non-communicable disease: best buys, wasted buys, and contestable buys. BMJ. 2020;368:m141. doi:1136/bmj.m141
  31. Rutter H, Savona N, Glonti K, et al. The need for a complex systems model of evidence for public health. Lancet. 2017;390(10112):2602-2604. doi:1016/s0140-6736(17)31267-9
  32. Collins T, Akselrod S, Berlina D, Allen LN. Unleashing implementation research to accelerate national noncommunicable disease responses. Global Health. 2022;18(1):6. doi:1186/s12992-021-00790-5
  33. Topp SM, Schaaf M, Sriram V, et al. Power analysis in health policy and systems research: a guide to research conceptualisation. BMJ Glob Health. 2021;6(11):e007268. doi:1136/bmjgh-2021-007268
  34. Greer SL, Falkenbach M, Siciliani L, McKee M, Wismar M, Figueras J. From health in all policies to health for all policies. Lancet Public Health. 2022;7(8):e718-e720. doi:1016/s2468-2667(22)00155-4
  35. Allen LN. Commercial determinants of global health. In: Haring R, Kickbusch I, Ganten D, Moeti M, eds. Handbook of Global Health. Cham: Springer International Publishing; 2020:1-37. doi:1007/978-3-030-05325-3_57-1
  36. World Health Organization (WHO). Guide for Staff on Engagement with Non‐State Actors Framework of Engagement with Non‐State Actors – WHO; 2018.
  37. Buse K, Aftab W, Akhter S, et al. Time to clarify State obligations and accountability on NCDs with human rights instruments. BMJ Glob Health. 2019;4(6):e002155. doi:1136/bmjgh-2019-002155
  38. Milsom P, Smith R, Baker P, Walls H. Corporate power and the international trade regime preventing progressive policy action on non-communicable diseases: a realist review. Health Policy Plan. 2021;36(4):493-508. doi:1093/heapol/czaa148
  39. Thow AM, Garde A, Winters LA, et al. Protecting noncommunicable disease prevention policy in trade and investment agreements. Bull World Health Organ. 2022;100(4):268-275. doi:2471/blt.21.287395
  40. Mohamed SF, Juma P, Asiki G, Kyobutungi C. Facilitators and barriers in the formulation and implementation of tobacco control policies in Kenya: a qualitative study. BMC Public Health. 2018;18(Suppl 1):960. doi:1186/s12889-018-5830-x
  41. Buse K, Tanaka S, Hawkes S. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure. Global Health. 2017;13(1):34. doi:1186/s12992-017-0255-3
  42. World Health Organization, Sheikh K, Abimbola S, Alliance for Health Policy and Systems Research. Learning Health Systems: Pathways to Progress: Flagship Report of the Alliance for Health Policy and Systems Research [Internet]. Geneva: World Health Organization; 2021. Available from: https://apps.who.int/iris/handle/10665/344891.
  43. Witter S, Palmer N, Balabanova D, et al. Health system strengthening-reflections on its meaning, assessment, and our state of knowledge. Int J Health Plann Manage. 2019;34(4):e1980-e1989. doi:1002/hpm.2882
  44. Collins T, Akselrod S, Berlina D, Allen LN. Unleashing implementation research to accelerate national noncommunicable disease responses. Global Health. 2022;18(1):6. doi:1186/s12992-021-00790-5
  45. Marten R, Mikkelsen B, Shao R, et al. Committing to implementation research for health systems to manage and control non-communicable diseases. Lancet Glob Health. 2021;9(2):e108-e109. doi:1016/s2214-109x(20)30485-x
  46. Jackson-Morris AM, Mutungi G, Maree E, Waqanivalu T, Marten R, Nugent R. 'Implementability' matters: using implementation research steps to guide and support non-communicable disease national planning in low-income and middle-income countries. BMJ Glob Health. 2022;7(4). doi:1136/bmjgh-2021-008275
  47. Lencucha R, Thow AM. How neoliberalism is shaping the supply of unhealthy commodities and what this means for NCD prevention. Int J Health Policy Manag. 2019;8(9):514-520. doi:15171/ijhpm.2019.56
  48. Mhazo AT, Maponga CC. Beyond political will: unpacking the drivers of (non) health reforms in sub-Saharan Africa. BMJ Glob Health. 2022;7(12):e010228. doi:1136/bmjgh-2022-010228
International Journal of Health Policy and Management
Volume 13, Issue 1
2024
Pages 1-14

XML
PDF 1.28 M
Supplementary File
(IJHPM does not take responsibility for any information provided in the supplementary files.)
Loffreda-Supple-File-1-IJHPM.pdf
Loffreda-Supple-File-2-IJHPM.pdf
Loffreda-Supple-File-3-IJHPM.pdf
Loffreda-Supple-File-4-IJHPM.pdf

  • Received Date 24 February 2023
  • Revised Date 06 November 2023
  • Accepted Date 30 December 2023
  • First Published Date 31 December 2023
  • Published Date 01 December 2024